Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9110986 | Cytokine | 2005 | 6 Pages |
Abstract
The effects of adenosine and subtype-specific activators of adenosine receptors (A1, A2A, A2B and A3) were studied on the release of interleukin-1β (IL-1β) from peripheral mononuclear cells, monocytes and lymphocytes. In the cells activated by the protein kinase C specific phorbol ester (phorbol 12-myristate 13-acetate) and Ca2+ ionophore (A23187) both adenosine and the subtype-specific receptor agonists, CPA (A1), CGS 21680 (A2A) and IB-MECA (A3) induced a concentration-dependent inhibition of IL-1β release. The rank order of potency in the inhibition of IL-1β release was CPA = CGS 21680 > IB-MECA > adenosine > NECA (in the presence of A1, A2A and A3 receptor inhibitors). The inhibitory actions of CPA, CGS 21680 or IB-MECA were significantly reduced in the presence of DPCPX, ZM 243185 or MRS 1191 as subtype-specific antagonists on A1, A2A and A3 adenosine receptors, respectively. It can be concluded that adenosine inhibits the release of IL-1β from the activated human peripheral mononuclear cells. In this process A1, A2A and A3 receptors are involved.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Sandor Sipka, Ildikó Kovács, Sándor Szántó, Gyula Szegedi, László Brugós, Geza Bruckner, A. József Szentmiklósi,